We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.25B
1-Year Est. Return 28.52%
This Fund
S&P 500
This Quarter Est. Return
+7.62%
1 Year Est. Return
+28.52%
3 Year Est. Return
+86.82%
5 Year Est. Return
+110.6%
10 Year Est. Return
+500.3%
AUM
$2.79B
AUM Growth
+$164M
Cap. Flow
-$30.9M
Cap. Flow %
-1.11%
Top 10 Hldgs %
20.45%
Holding
3,380
New
284
Increased
506
Reduced
861
Closed
334

Top Buys

Rank Stock Value
1
AFL icon
Aflac
AFL
+$2.88M
2
AZPN
ASPEN TECHNOLOGY INC
AZPN
+$2.53M
3
TRGP icon
Targa Resources
TRGP
+$2.39M
4
UNP icon
Union Pacific
UNP
+$2.39M
5
G icon
Genpact
G
+$2.13M

Sector Composition

Rank Sector Weight
1 Technology 17.21%
2 Financials 10.71%
3 Consumer Discretionary 10.62%
4 Healthcare 9.54%
5 Industrials 9.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TER icon
276
Teradyne
TER
$59.3B
$2.24M 0.08%
16,697
-505
-3% -$64.6K
ADI icon
277
Analog Devices
ADI
$188B
$2.23M 0.08%
12,972
+137
+1% +$21.9K
LSI
278
DELISTED
Life Storage, Inc.
LSI
$2.22M 0.08%
20,690
LHCG
279
DELISTED
LHC Group LLC
LHCG
$2.19M 0.08%
10,954
-246
-2% -$49.3K
AGCO icon
280
AGCO
AGCO
$7.1B
$2.18M 0.08%
16,701
-273
-2% -$38.4K
UTHR icon
281
United Therapeutics
UTHR
$22.1B
$2.17M 0.08%
12,108
-174
-1% -$33.1K
CTVA icon
282
Corteva
CTVA
$50.9B
$2.15M 0.08%
48,530
-879
-2% -$40.6K
PM icon
283
Philip Morris
PM
$290B
$2.15M 0.08%
21,691
-257
-1% -$24.7K
HALO icon
284
Halozyme
HALO
$11.6B
$2.15M 0.08%
47,226
+1,290
+3% +$57.1K
G icon
285
Genpact
G
$5.71B
$2.14M 0.08%
+47,085
New +$2.13M
ITT icon
286
ITT
ITT
$19.4B
$2.13M 0.08%
23,272
-607
-3% -$56.5K
SMG icon
287
ScottsMiracle-Gro
SMG
$3.61B
$2.12M 0.08%
11,055
-158
-1% -$34.9K
JBL icon
288
Jabil
JBL
$37.4B
$2.1M 0.08%
36,197
-1,002
-3% -$55.1K
EHC icon
289
Encompass Health
EHC
$12.4B
$2.1M 0.08%
33,820
-391
-1% -$26.1K
LIN icon
290
Linde
LIN
$226B
$2.09M 0.07%
7,219
-129
-2% -$37.6K
UPS icon
291
United Parcel Service
UPS
$88.8B
$2.09M 0.07%
10,033
-77
-0.8% -$15.4K
FSLR icon
292
First Solar
FSLR
$25.9B
$2.08M 0.07%
22,988
-443
-2% -$35.1K
DLR icon
293
Digital Realty Trust
DLR
$70.6B
$2.07M 0.07%
13,753
-324
-2% -$49K
ASH icon
294
Ashland
ASH
$3.42B
$2.06M 0.07%
23,568
-300
-1% -$27K
REXR icon
295
Rexford Industrial Realty
REXR
$8.07B
$2.05M 0.07%
36,074
CHE icon
296
Chemed
CHE
$7.02B
$2.05M 0.07%
4,311
-98
-2% -$47.1K
REGN icon
297
Regeneron Pharmaceuticals
REGN
$82.1B
$2.05M 0.07%
3,663
ZD icon
298
Ziff Davis
ZD
$1.97B
$2.05M 0.07%
17,110
-334
-2% -$36.7K
MRNA icon
299
Moderna
MRNA
$24.2B
$2.04M 0.07%
8,664
+187
+2% +$33.4K
RGLD icon
300
Royal Gold
RGLD
$19.8B
$2.02M 0.07%
17,733
-399
-2% -$47.1K

Similar funds

Ameritas Investment Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Ameritas Investment Partners held 3,380 positions worth $2.79B, up 6.2% from $2.62B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Ameritas Investment Partners's Q2 2021 filing shows 284 new, 506 increased, 861 reduced and 334 closed positions. Its largest new stake was ASPEN TECHNOLOGY INC: 18,384 shares worth $2.53M. The largest sale was Charles River Laboratories, an estimated $5.13M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Ameritas Investment Partners's largest Q2 2021 buy was ASPEN TECHNOLOGY INC: 18,384 shares worth $2.53M.
  • Ameritas Investment Partners added most to Aflac in Q2 2021, an estimated $2.88M increase.
  • Ameritas Investment Partners's biggest Q2 2021 reduction was Charles River Laboratories, cutting an estimated $5.13M.
  • Ameritas Investment Partners fully exited TCF Financial Corporation Common Stock in Q2 2021, selling an estimated $1.96M.
  • Ameritas Investment Partners's ten largest holdings make up 20% of its $2.79B portfolio in Q2 2021.
  • Ameritas Investment Partners opened 284 new positions and closed 334 in Q2 2021.
  • Ameritas Investment Partners's portfolio value rose 6.2% quarter-over-quarter to $2.79B.

Based on Ameritas Investment Partners's 13F filing for Q2 2021, filed 6 Aug 2021.